Published in Annals of internal medicine
Several vaccine candidates to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (COVID-19) have entered or will soon enter large-scale, phase 3, placebo-controlled randomized clinical trials. To facilitate harmonized evaluation and comparison of the efficacy of these vaccines, a gener...
Published in Annals of internal medicine
Singapore is one of the most densely populated small island-states in the world. During the coronavirus disease 2019 (COVID-19) pandemic, Singapore implemented large-scale institutional isolation units called Community Care Facilities (CCFs) to combat the outbreak in the community by housing low-risk COVID-19 patients from April to August 2020. The...
Published in Annals of internal medicine
Published in Annals of internal medicine
Published in Annals of internal medicine
Published in Annals of internal medicine
Published in Annals of internal medicine
Published in Annals of internal medicine
Few treatments exist for coronavirus disease 2019 (COVID-19). To evaluate the effectiveness and harms of remdesivir for COVID-19. Several databases, tables of contents of journals, and U.S. Food and Drug Administration and company websites were searched from 1 January through 31 August 2020. English-language, randomized trials of remdesivir treatme...
Published in Annals of internal medicine
Published in Annals of internal medicine
